{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68210-4096",
      "generic_name": "NAPROXEN SODIUM",
      "labeler_name": "SPIRIT PHARMACEUTICALS,LLC",
      "brand_name": "NAPROXEN SODIUM",
      "active_ingredients": [
        {
          "name": "NAPROXEN SODIUM",
          "strength": "220 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68210-4096-1",
          "description": "365 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-4096-1)",
          "marketing_start_date": "20200702",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "SPIRIT PHARMACEUTICALS,LLC"
        ],
        "spl_set_id": [
          "a690dc39-95f2-4853-a291-05d7dc9a1551"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "9TN87S3A3C"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
      "spl_id": "2a8235d0-4618-0572-e063-6394a90a0d1a",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200702",
      "product_id": "68210-4096_2a8235d0-4618-0572-e063-6394a90a0d1a",
      "application_number": "ANDA091353",
      "brand_name_base": "NAPROXEN SODIUM",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]"
      ]
    }
  ]
}